Never miss a story

Get subscribed to our newsletter


×
This new type of bed net can help prevent malaria: Lancet. (VOA)

An experimental new malaria vaccine is offering potentially long-lasting immunity against the persistent parasite that sickens hundreds of millions of people each year, a study suggests.

Most vaccines are designed to encourage the human body to respond to invading, disease-causing pathogens by creating antibodies that disable those pathogens.


However, the new vaccine takes a different approach by using a weakened form of a common herpes virus – cytomegalovirus, or CMV – that infects most people without causing the disease.

This new vaccine reduced the malaria-causing parasite’s release from the liver and into the blood of infected rhesus macaques by 75 to 80 per cent, reported the paper published in the journal PLOS ONE.

“The problem with most vaccines is that their effectiveness is often short-lived,” said lead author Klaus Fruh, professor at the Oregon Health and Science University in the US.


More people die of malaria than anything else in the world.

“Our cytomegalovirus-based vaccine platform can create and keep immunity for life. With further research and development, it could offer a lifetime of protection against malaria,” Fruh added.

Malaria is a serious and sometimes fatal disease caused by Plasmodium parasites, which are spread to humans through mosquito bites.

It can cause high fevers, shaking chills, flu-like illness and, in the worst cases, death.

Worldwide, 216 million people were infected with malaria in 2016, leading to 445,000 deaths.

Fruh and his team weaved tiny bits of their target pathogen into CMV, which is already being used in vaccines being developed to battle HIV and tuberculosis.

Those who receive the resulting, re-engineered CMV vaccine produce memory T-cells that can search for and destroy pathogen-infected cells.


A health service worker takes a blood sample for a malaria test in Dajabon, Dominican Republic, on the border with Haiti, Oct. 6, 2009. A test that doesn’t require a needle or blood has won the Africa Prize for Engineering Innovation, VOA

The team developed two different versions of their CMV-based malaria vaccine while using four different proteins made by the Plasmodium parasite.

The resulting vaccines delayed the parasite’s appearance in the blood of 16 infected and vaccinated rhesus macaques by eliminating between 75 and 80 per cent of parasites from the liver.

Also Read- Deficiency of Zinc May up Hypertension

A year later, the vaccinated non-human primates still had immunity against malaria, while eight control animals that were not vaccinated did not.

The CMV vaccine platform has been licensed by San Francisco-based Vir Biotechnology, which plans to lead a human clinical trial for a CMV-based HIV vaccine in 2019. (IANS)


Popular

qz.com

China is cracking down on cryptocurrency

A cryptocurrency is a digital/virtual currency, that is secured by cryptography (study of hiding information). There are over 6,500 cryptocurrencies in existence as of September 2021. The value of cryptocurrency is growing at a quick rate and analysts and experts are still expecting a sharp rise in the value of Bitcoin, the oldest, and most valuable cryptocurrency in the world. however, china doesn't seem to be on board with the idea of digital coins in its economy as it has banned dealing and trading in these digital tokens.

China has taken several decisions to curb the rise of cryptocurrency in its market since 2013 by putting in place increasingly stricter rules on virtual currencies. But on September 17th, China's central People's Bank of China (PBOC) announced that all activities from transactions made in cryptocurrency to crypto mining are deemed illegal including offering trading of digital assets, order matching, token issuance and derivatives. Anyone who's found guilty of being involved with cryptocurrencies and working for overseas platforms from within China will be severely punished. Chinese Government directed the banks to not provide any products or services such as trading, clearing and settlement for cryptocurrency transactions.

Keep Reading Show less
DRDO Twitter

"Akash Prime" was successfully tested by the DRDO by the ITR in Odisha's Chandipur

A new version of the Akash missile- "Akash Prime" was successfully tested by the Defence Research and Development Organisation (DRDO) at the Integrated Test Range in Odisha's Chandipur on Monday at around 4:30 pm. The missile intercepted and tore apart a high-speed unmanned aerial target mimicking enemy aircraft, in its first flight test after all the enhancements.

Akash Prime is equipped with an indigenous active Radio Frequency seeker to accurately locate the enemy aircraft. The upgrade includes an improved, Launcher, Multi-Function Radar and Command, Control and Communication system. The test was carried out amidst bad weather conditions and yet Akash Prime successfully detonated the threat proving the all-weather capability of the weapon system. The improvements also established that the new missile has comparatively more reliable performance under a low-temperature environment at higher altitudes

Keep Reading Show less
Photo by Kelly Sikkema on Unsplash

According to research, virtual learning has been proven to enhance retention of information and take up less time

"Education is the most powerful weapon which you can use to change the world."
-N
elson Mandela


Schools all across the world have been closed as a result of the COVID-19 outbreak. Over 1.2 billion children are out of school across the globe. (Reported by UNICEF). Because of this, education has changed immensely, with the introduction of e-learning, in which tutoring is provided remotely and using various digital platforms. According to research, virtual learning has been proven to enhance retention of information and take up less time, indicating that the changes produced by the coronavirus may be here to stay in the future.

Keep reading... Show less